EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Unravelling mesenteric fibrosis in small intestinal neuroendocrine tumours and implications for clinical management

Maria Castanho Martins iD, Eva van der Slik, Johannes Hofland iD, Anela Blažević iD, Harry Hodgetts iD, Dalvinder Mandair, Christos Toumpanakis, Martyn E Caplin, Leo J Hofland iD, Wouter W de Herder iD, Krista Rombouts iD, Richard A Feelders

Endocrine-Related Cancer · 01.05.2026 · 33 (5)

DOI: 10.1530/erc-25-0116 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Endocrine-Related Cancer, online erschienen am 20.04.2026. Verfasst von Maria Castanho Martins und 11 weiteren Autor:innen. Beteiligte Einrichtung: Regenerative Medicine and Fibrosis Group, Institute for Liver and Digestive Health, Royal Free Hospital, University College London, London, UK. Hauptthemen laut MEDLINE: Neuroendocrine Tumors, Intestinal Neoplasms, Intestine, Small, Peritoneal Fibrosis. Die Arbeit nennt 193 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mesenteric fibrosis (MF) is an extensive fibrotic reaction common in small intestine neuroendocrine tumours (SI-NETs) and develops around mesenteric metastasis. While primary SI-NETs can remain asymptomatic for years, mesenteric metastasis (MM) and the resulting MF frequently leads to serious complications. Despite its clear impact on quality of life, MF pathophysiology remains poorly understood and treatment options are currently limited to surgical interventions. This review summarizes the literature on MF in SI-NET patients, emphasizing gaps in knowledge and potential research directions. Clinical research confirms that MF is a frequent complication, often causing severe morbidity, including mesenteric ischaemia and obstruction. Addressing these issues requires further research into MF pathogenesis and contributory factors, such as elastic vascular sclerosis (EVS), which are currently underexplored. Advancing this field will necessitate collaboration, supported by clear definitions and standardized diagnostic and grading systems for MF linked to clinical data, which are presently lacking. While MF-directed translational research remains scarce, recent studies focusing on tumour microenvironment have begun to uncover possible pathways involved in MF. Serotonin, pro-fibrotic growth factors and cytokines may play a role in activating cancer-associated fibroblasts and immune cells within the tumour microenvironment, aggravating extracellular matrix protein deposition and possibly creating positive feedback loops that promote fibrosis. Recently classified as an organ, the mesentery may harbour unique properties for stimulating the establishment of MF. Emerging research is paving the way for new MF treatment options that are urgently needed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neuroendocrine TumorsIntestinal NeoplasmsIntestine, SmallPeritoneal FibrosisMesenteryHumansAnimalsFibrosis

Stichwörter der Autor:innen

mesenteric fibrosismesenteric metastasisnarrative reviewsmall intestinal neuroendocrine tumour

Autor:innen und Institutionen

  • Regenerative Medicine and Fibrosis Group, Institute for Liver and Digestive Health, Royal Free Hospital, University College London, London, UK.
  • Department of Internal Medicine, Sector Endocrinology, ENETS Center of Excellence, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
  • Neuroendocrine Tumour Unit, ENETS Centre of Excellence, Royal Free London NHS Foundation Trust, London, UK.
  • Holman Division of Endocrinology, Diabetes and Metabolism, New York University Langone Medical Center, New York, USA.

ORCID-Profile: Maria Castanho Martins, Johannes Hofland, Anela Blažević, Harry Hodgetts, Leo J Hofland, Wouter W de Herder, Krista Rombouts

Zitieren

APA

Castanho Martins, M., van der Slik, E., Hofland, J., Blažević, A., Hodgetts, H., Mandair, D., Toumpanakis, C., Caplin, M. E., Hofland, L. J., de Herder, W. W., Rombouts, K., & Feelders, R. A. (2026). Unravelling mesenteric fibrosis in small intestinal neuroendocrine tumours and implications for clinical management. Endocrine-Related Cancer, 33(5). https://doi.org/10.1530/erc-25-0116

Vancouver

Castanho Martins M, van der Slik E, Hofland J, Blažević A, Hodgetts H, Mandair D, et al. Unravelling mesenteric fibrosis in small intestinal neuroendocrine tumours and implications for clinical management. Endocrine-Related Cancer. 2026;33(5). doi:10.1530/erc-25-0116

BibTeX
@article{CastanhoMartins2026,
  author = {Castanho Martins, Maria and van der Slik, Eva and Hofland, Johannes and Blažević, Anela and Hodgetts, Harry and Mandair, Dalvinder and Toumpanakis, Christos and Caplin, Martyn E and Hofland, Leo J and de Herder, Wouter W and Rombouts, Krista and Feelders, Richard A},
  title = {Unravelling mesenteric fibrosis in small intestinal neuroendocrine tumours and implications for clinical management},
  journal = {Endocrine-Related Cancer},
  year = {2026},
  volume = {33},
  number = {5},
  doi = {10.1530/erc-25-0116}
}
Kostenlos starten →